BofA analyst Joshua Shanker lowered the firm’s price target on Marsh McLennan (MMC) to $238 from $264 and keeps a Neutral rating on the shares following the Q1 report. The firm expects the company’s organic growth to slow down as GDP growth decelerates and fiduciary income tailwinds from high interest rates subside. It cites multiple contraction for the target cut.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMC:
- Balanced Outlook for Marsh & McLennan: Hold Rating Amid Mixed Performance Indicators
- Balanced Outlook on Marsh & McLennan: Hold Rating Amid Growth and Cost Challenges
- Stock Market Recap: Eli Lilly Soars, UnitedHealth Crashes, Financials Lead Sector Gains
- Marsh McLennan Reports Strong Q1 2025 Results
- Marsh & McLennan’s Earnings Call: Growth Amid Challenges